Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

'On-off switch' brings researchers a step closer to potential HIV vaccine

30.03.2017

Scientists say the innovation could put their vaccine candidate among the safest yet reported

By engineering an on/off switch into a weakened form of HIV, University of Nebraska-Lincoln researchers have enhanced the safety and effectiveness of a potential vaccine for the virus that has killed approximately 35 million people during the past 35 years.


This is an illustration of human immunodeficiency virus.

Original illustration: Angie Fox, University of Nebraska State Museum

In a recent study, the team demonstrated that flipping the switch allows weakened HIV to replicate at a level likely to generate immunity in a host. The researchers then used their approach to switch off this replication at will, a feat that the team said could make its vaccine candidate among the safest yet reported.

"Safety is always our biggest concern," said Wei Niu, associate professor of chemical and biomolecular engineering. "In this case, (it means) we're one step closer to generating a vaccine."

Vaccinologists often prefer exposing the body to weakened viruses, rather than deactivated ones, because they confer stronger and longer-lasting immunity. But weakened viruses retain the ability to replicate, meaning that they still pose a risk of becoming full-blown pathogens. The Nebraska team began addressing this issue in 2014, when it genetically engineered a version of HIV that needs a synthetic amino acid -- one not found in the body -- to replicate.

Doing so required the team to replace a three-nucleotide sequence, or sense codon, in HIV's genetic code. Each codon instructs the aptly named transfer-RNA to add its corresponding amino acid to a chain that becomes a protein and ultimately allows viral replication. So the team swapped out one of these sense codons for a "nonsense" edition that instead signals a stop in the amino-acid assembly line, halting production of the proteins essential to replication.

The researchers then engineered a unique tRNA and accompanying enzyme that together could make sense of the nonsense - that is, interpret it as a sense codon. When the team supplied this tRNA pair with a synthetic amino acid, the assembly line began churning out proteins, and the virus began replicating. When the supply of amino acids stopped, so did the replication.

This technique gave the team control over the HIV's replication, but it triggered only one cycle of infection - not enough to yield immunity. The researchers have now managed to embed their genetic switch inside the HIV genome, so that each copy of the virus contains the switch and has the capacity to replicate. And by delivering a consistent supply of amino acids, the team showed that it can kick-start the multiple cycles of replication necessary for an effective vaccine.

"The machinery can be carried to the next cycle and the next cycle," said Zhe Yuan, doctoral student in biological sciences. "It's much easier to control feeding or (restriction) of the unnatural amino acid."

Other research teams have already managed to generate HIV immunity in organisms, with one vaccine protecting 95 percent of rhesus monkeys against the virus. Many such vaccines have relied on deleting HIV genes to limit replication, but the virus' penchant for mutating can help it overcome this defense and replicate unchecked.

Qingsheng Li, professor of biological sciences, said the team's combination of nonsense codon, genetic switch and synthetic amino acid represents an especially stringent set of safeguards against unchecked replication. That quality could expand its use against an array of viruses far removed from HIV, he said.

Adding more nonsense codons would further reduce the likelihood of a dangerous mutation, Niu said, and the team plans to explore this possibility in the near future. Though the researchers have so far evaluated their vaccine only in the petri dish, they hope to begin small-animal trials in the next year.

"That's the big milestone," said Li, professor of biological sciences and member of the Nebraska Center for Virology. "If that works well, we need to go to the pre-clinical animal model before going to a clinical trial. That's our goal and road map."

Niu, Yuan and Li authored the study with Nanxi Wang, doctoral student in chemistry; Jintao Guo, associate professor of chemistry; and Guobin Kang, research technologist with the Nebraska Center for Virology.

"This is truly multidisciplinary research that would have been difficult to complete by either research group working alone," Guo said.

###

The researchers' study appeared in the journal ACS Synthetic Biology. They received support from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, under grant 1R01AI111862.

Media Contact

Qingsheng Li, biological sciences, UNL
qli@unl.edu
402-472-5922

 @UNLNews

http://www.unl.edu 

Qingsheng Li, biological sciences, UNL | EurekAlert!

More articles from Health and Medicine:

nachricht Penn study identifies new malaria parasites in wild bonobos
21.11.2017 | University of Pennsylvania School of Medicine

nachricht NIST scientists discover how to switch liver cancer cell growth from 2-D to 3-D structures
17.11.2017 | National Institute of Standards and Technology (NIST)

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Nanoparticles help with malaria diagnosis – new rapid test in development

The WHO reports an estimated 429,000 malaria deaths each year. The disease mostly affects tropical and subtropical regions and in particular the African continent. The Fraunhofer Institute for Silicate Research ISC teamed up with the Fraunhofer Institute for Molecular Biology and Applied Ecology IME and the Institute of Tropical Medicine at the University of Tübingen for a new test method to detect malaria parasites in blood. The idea of the research project “NanoFRET” is to develop a highly sensitive and reliable rapid diagnostic test so that patient treatment can begin as early as possible.

Malaria is caused by parasites transmitted by mosquito bite. The most dangerous form of malaria is malaria tropica. Left untreated, it is fatal in most cases....

Im Focus: A “cosmic snake” reveals the structure of remote galaxies

The formation of stars in distant galaxies is still largely unexplored. For the first time, astron-omers at the University of Geneva have now been able to closely observe a star system six billion light-years away. In doing so, they are confirming earlier simulations made by the University of Zurich. One special effect is made possible by the multiple reflections of images that run through the cosmos like a snake.

Today, astronomers have a pretty accurate idea of how stars were formed in the recent cosmic past. But do these laws also apply to older galaxies? For around a...

Im Focus: Visual intelligence is not the same as IQ

Just because someone is smart and well-motivated doesn't mean he or she can learn the visual skills needed to excel at tasks like matching fingerprints, interpreting medical X-rays, keeping track of aircraft on radar displays or forensic face matching.

That is the implication of a new study which shows for the first time that there is a broad range of differences in people's visual ability and that these...

Im Focus: Novel Nano-CT device creates high-resolution 3D-X-rays of tiny velvet worm legs

Computer Tomography (CT) is a standard procedure in hospitals, but so far, the technology has not been suitable for imaging extremely small objects. In PNAS, a team from the Technical University of Munich (TUM) describes a Nano-CT device that creates three-dimensional x-ray images at resolutions up to 100 nanometers. The first test application: Together with colleagues from the University of Kassel and Helmholtz-Zentrum Geesthacht the researchers analyzed the locomotory system of a velvet worm.

During a CT analysis, the object under investigation is x-rayed and a detector measures the respective amount of radiation absorbed from various angles....

Im Focus: Researchers Develop Data Bus for Quantum Computer

The quantum world is fragile; error correction codes are needed to protect the information stored in a quantum object from the deteriorating effects of noise. Quantum physicists in Innsbruck have developed a protocol to pass quantum information between differently encoded building blocks of a future quantum computer, such as processors and memories. Scientists may use this protocol in the future to build a data bus for quantum computers. The researchers have published their work in the journal Nature Communications.

Future quantum computers will be able to solve problems where conventional computers fail today. We are still far away from any large-scale implementation,...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Ecology Across Borders: International conference brings together 1,500 ecologists

15.11.2017 | Event News

Road into laboratory: Users discuss biaxial fatigue-testing for car and truck wheel

15.11.2017 | Event News

#Berlin5GWeek: The right network for Industry 4.0

30.10.2017 | Event News

 
Latest News

Previous evidence of water on mars now identified as grainflows

21.11.2017 | Physics and Astronomy

NASA's James Webb Space Telescope completes final cryogenic testing

21.11.2017 | Physics and Astronomy

New catalyst controls activation of a carbon-hydrogen bond

21.11.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>